(Q33489827)

27 July 2017

Occurrence of disseminated intravascular coagulation (DIC) in active systemic anaphylaxis: role of platelet-activating factor (English)

1 reference

disseminated intravascular coagulation

27 July 2017

0 references

1 reference

1 reference

Choi IH

1

1 reference

27 July 2017

Ha TY

2

1 reference

27 July 2017

Lee DG

3

1 reference

27 July 2017

Park JS

4

1 reference

27 July 2017

Lee JH

5

1 reference

27 July 2017

Park YM

6

1 reference

27 July 2017

Lee HK

7

1 reference

27 July 2017

1 June 1995

1 reference

Clinical and Experimental Immunology

27 July 2017

1 reference

27 July 2017

100

1 reference

27 July 2017

3

1 reference

27 July 2017

390-394

1 reference

Pharmacological control of the in vivo passive anaphylactic shock by the PAF-acether antagonist compound BN 52021.

27 July 2017

1 reference

12 December 2020

Possible role of platelet activating factor (PAF) in disseminated intravascular coagulation (DIC), evidenced by use of a PAF antagonist, CV-3988.

1 reference

12 December 2020

Perspectives in platelet-activating factor research

1 reference

12 December 2020

Tumor necrosis factor/cachectin stimulates peritoneal macrophages, polymorphonuclear neutrophils, and vascular endothelial cells to synthesize and release platelet-activating factor

1 reference

12 December 2020

Synthesis and release of platelet-activating factor is inhibited by plasma alpha 1-proteinase inhibitor or alpha 1-antichymotrypsin and is stimulated by proteinases

1 reference

12 December 2020

Biphasic platelet-activating factor synthesis by human monocytes stimulated with IL-1-beta, tumor necrosis factor, or IFN-gamma.

1 reference

12 December 2020

Tumor necrosis factor infusions have a procoagulant effect on the hemostatic mechanism of humans

1 reference

12 December 2020

Production of active and passive anaphylactic shock in the WBB6F1 mouse, a mast cell-deficient strain

1 reference

12 December 2020

Protective effect of SR 27417, a novel PAF antagonist, on lethal anaphylactic and endotoxin-induced shock in mice

1 reference

12 December 2020

Effect of a selective PAF antagonist SM-10661 ((±)-cis-3,5-dimethyl-2-(3-pyridyl)thiazolidin-4-one HCl) on experimental disseminated intravascular coagulation (DIC)

1 reference

12 December 2020

Inhibitory effect of TCV-309, a novel platelet activating factor (PAF) antagonist, on endotoxin-induced disseminated intravascular coagulation in rats: possible role of PAF in tissue factor generation

1 reference

12 December 2020

Pathogenesis of disseminated intravascular coagulation in sepsis

1 reference

12 December 2020

The reproducibility and constancy of the platelet count

1 reference

12 December 2020

Biology of immunoglobulin E. Molecular basis of reaginic hypersensitivity

1 reference

12 December 2020

Interleukin 1 (IL-1) induces biosynthesis and cell surface expression of procoagulant activity in human vascular endothelial cells

1 reference

12 December 2020

Inhibition by CV-3988 of the binding of [3H]-platelet activating factor (PAF) to the platelet

1 reference

12 December 2020

Involvement of platelet activating factor in respiratory anaphylaxis, demonstrated by PAF-acether inhibitor BN 52021

1 reference

12 December 2020

Modulation of endothelial cell hemostatic properties by tumor necrosis factor

1 reference

12 December 2020

Immune response potential of mast cell-deficient W/Wv mice

1 reference

12 December 2020

Interleukin 1 stimulates platelet-activating factor production in cultured human endothelial cells

1 reference

12 December 2020

Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: characterization and comparison with the actions of interleukin 1

1 reference

12 December 2020

Systemic anaphylaxis in mast-cell-deficient mice of W/Wv and Sl/Sld genotypes

1 reference

12 December 2020

10.1111/J.1365-2249.1995.TB03711.X

Identifiers

DOI

1 reference

27 July 2017

1 reference